Literature DB >> 9892238

Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.

M Anai1, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka, T Asano.   

Abstract

Insulin receptor substrate (IRS)-1 and IRS-2, which mediate phosphatidylinositol (PI) 3-kinase activation, play essential roles in insulin-induced translocation of GLUT4 and in glycogen synthesis. In this study, we investigated the process of PI 3-kinase activation via binding with IRS-1 and -2 in liver, muscle, and fat of high-fat-fed rats, a model of insulin-resistant diabetes. In the liver of high-fat-fed rats, insulin increased the PI 3-kinase regulatory subunit p85alpha and the PI 3-kinase activities associated with IRS-1 3.6- and 2.4-fold, and with IRS-2, 4.7- and 3.0-fold, respectively, compared with those in control rats. The tyrosine phosphorylation levels of IRS-1 and IRS-2 were not significantly altered, however. In contrast with the liver, tyrosine phosphorylation levels and associated PI 3-kinase proteins and activities were decreased in the muscle and adipose tissue of high-fat-fed rats. Thus, high-fat feeding appears to cause insulin resistance in the liver by a mechanism different from the impaired PI 3-kinase activation observed in muscle and adipose tissue. Taking into consideration that hepatic PI 3-kinase activation is severely impaired in obese diabetic models such as Zucker fatty rats, it is possible that the mechanism by which a high-fat diet causes insulin resistance is quite different from that associated with obesity and overeating due to abnormality in the leptin system. This is the first report to show increased PI 3-kinase activation by insulin in an insulin-resistant diabetic animal model. These findings may be important for understanding the mechanism of insulin resistance in human NIDDM, since a high-fat diet is considered to be one of the major factors exacerbating insulin insensitivity in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892238     DOI: 10.2337/diabetes.48.1.158

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  The influence of dietary fat on insulin resistance.

Authors:  Jennifer C Lovejoy
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 2.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.

Authors:  T-F Tzeng; I-M Liu; J-T Cheng
Journal:  Diabetologia       Date:  2005-06-15       Impact factor: 10.122

4.  Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.

Authors:  E Lefai; M Roques; N Vega; M Laville; H Vidal
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

5.  Fish oil normalizes plasma glucose levels and improves liver carbohydrate metabolism in rats fed a sucrose-rich diet.

Authors:  Gustavo J Hein; Adriana Chicco; Yolanda B Lombardo
Journal:  Lipids       Date:  2011-11-02       Impact factor: 1.880

6.  Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.

Authors:  Joel T Haas; Ji Miao; Dipanjan Chanda; Yanning Wang; Enpeng Zhao; Mary E Haas; Matthew Hirschey; B Vaitheesvaran; Robert V Farese; Irwin J Kurland; Mark Graham; Rosanne Crooke; Fabienne Foufelle; Sudha B Biddinger
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

7.  Acute impairment of insulin signalling by dexamethasone in primary cultured rat skeletal myocytes.

Authors:  Paul D Brown; Simone Badal; Seian Morrison; Dalip Ragoobirsingh
Journal:  Mol Cell Biochem       Date:  2006-10-28       Impact factor: 3.396

8.  Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.

Authors:  Xu-qiang Nie; Huai-hong Chen; Jian-yong Zhang; Yu-jing Zhang; Jian-wen Yang; Hui-jun Pan; Wen-xia Song; Ferid Murad; Yu-qi He; Ka Bian
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

9.  Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats.

Authors:  Hiraku Ono; Alessandro Pocai; Yuhua Wang; Hideyuki Sakoda; Tomoichiro Asano; Jonathan M Backer; Gary J Schwartz; Luciano Rossetti
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.

Authors:  Mini P Sajan; Mary L Standaert; Sonali Nimal; Usha Varanasi; Tina Pastoor; Stephen Mastorides; Ursula Braun; Michael Leitges; Robert V Farese
Journal:  J Lipid Res       Date:  2009-02-06       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.